EGFR is a verified therapeutic target; antibody drugs such as cetuximab and panitumumab, which target the transmembrane protein epidermal growth factor receptor (EGFR), have made a major step forward in the treatment of cancer.52, 53. Here, EGFR is linked to cancer.